| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $501,436,321 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01AG094588 | In vitro pharmacology, chronic toxicology, and embryo-fetal development studies to demonstrate safety of GSM-779690 | 001 | 2 | NIH | 8/3/2026 | $1,744,718 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | UM1TR005449 | CTSA UM1 Program at University of California San Diego Altman Clinical and Translational Research Institute | 000 | 2 | NIH | 4/30/2026 | $10,295,345 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01NS144158 | Mechanisms of pathogenic microglial populations in CNS inflammation | 000 | 2 | NIH | 7/13/2026 | $524,571 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R35GM156288 | Regulated assembly and function of macromolecular complexes in genome maintenance | 000 | 2 | NIH | 1/14/2026 | $137,346 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AG087407 | Intrinsic CSF outflow metrics for mild cognitive impairment and Alzheimer's disease | 000 | 3 | NIH | 2/26/2026 | $765,357 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R25MH108389 | Sustained Training in Aging and HIV Research (STAHR) | 000 | 9 | NIH | 3/23/2026 | $209,974 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R21CA289083 | Cancer therapy by targeting innate immune cells in vivo using novel virus-like particles | 001 | 2 | NIH | 4/16/2026 | $18,660 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R21CA289083 | Cancer therapy by targeting innate immune cells in vivo using novel virus-like particles | 000 | 2 | NIH | 2/18/2026 | $167,950 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01CA167426 | Role of PI3Kgamma in Tumor Progression and Metastasis | 000 | 14 | NIH | 7/27/2026 | $535,870 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01MH130396 | Transdiagnostic Reward System Dynamics and Social Disconnection in Suicide | 000 | 4 | NIH | 2/16/2026 | $770,556 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R25HL145817 | UCSD Future Faculty of Cardiovascular Sciences (FOCUS) | 000 | 8 | NIH | 3/20/2026 | $342,360 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | P50HD106463 | Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses | 001 | 5 | NIH | 8/24/2026 | $500,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | P50HD106463 | Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses | 001 | 5 | NIH | 8/24/2026 | $690,453 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01DA063213 | Responding to the Increase in Substance Use, HIV, HCV, and Overdose in New England (RISE-NE) | 001 | 2 | NIH | 6/11/2026 | $2,468,276 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01DK136117 | Reverse Metabolomics for the Discovery of Disease Associated Microbial Molecules | 000 | 4 | NIH | 2/19/2026 | $707,221 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01ES025792 | Cyclical Alterations In Neurocognitive Performance And Mood Over Two Years In Relation To Pesticide Spray Seasons Among Adolescent And Young Adult Participants Of The Espina Study. | 001 | 10 | NIH | 3/9/2026 | $96,412 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01ES025792 | Cyclical Alterations In Neurocognitive Performance And Mood Over Two Years In Relation To Pesticide Spray Seasons Among Adolescent And Young Adult Participants Of The Espina Study. | 000 | 10 | NIH | 3/5/2026 | $502,346 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U24DK097771 | dkNET Coordinating Unit: Harnessing the Power of AI and Data Science forCollaborative Discovery and Sharing in the DK Community | 001 | 13 | NIH | 8/14/2026 | $300,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U24DK097771 | dkNET Coordinating Unit: Harnessing the Power of AI and Data Science forCollaborative Discovery and Sharing in the DK Community | 000 | 13 | NIH | 3/19/2026 | $2,000,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U2RTW012228 | 2/2 GeoHealth Hub on Environmental Exposure and Health in the Arab Region-U.S | 000 | 5 | NIH | 7/31/2026 | $117,729 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U2RTW012228 | 2/2 GeoHealth Hub on Environmental Exposure and Health in the Arab Region-U.S | 000 | 5 | NIH | 7/31/2026 | $73,901 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U2RTW012228 | 2/2 GeoHealth Hub on Environmental Exposure and Health in the Arab Region-U.S | 000 | 5 | NIH | 7/31/2026 | $100,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | K99DA060978 | From Childhood to Adulthood: the Co-occurrence of Trauma, Substance Use, and Additional Stressors | 000 | 2 | NIH | 6/24/2026 | $158,246 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01HL139001 | MMP responsive polymeric materials for treating acute myocardial infarction | 000 | 8 | NIH | 7/6/2026 | $568,165 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01HL173155 | Blood Pressure Care for Advancing Real-World Evidence (BPCARE): An RCT of Adherence | 000 | 2 | NIH | 8/4/2026 | $634,296 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01DA056058 | Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV | 000 | 5 | NIH | 4/7/2026 | $896,116 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | K08NS123543 | Defining the forebrain neurophysiological representation of pain | 000 | 4 | NIH | 12/22/2025 | $195,561 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | T32DK142622 | Multidisciplinary Research Training in Digestive Physiology and Diseases | 000 | 2 | NIH | 7/2/2026 | $364,449 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01DE035393 | Targeting Systems Vulnerabilities in the EGFR/HER3/HER2 Oncogenic Signaling Circuitry: New Precision Therapies for Oral Cancer | 000 | 2 | NIH | 6/10/2026 | $486,400 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01HL166485 | The cardiovascular consequences of sleep apnea plus COPD (Overlap syndrome) | 000 | 4 | NIH | 8/3/2026 | $751,758 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01EY029259 | Circuit Engagement in Prosthetically Driven Retina | 000 | 7 | NIH | 6/2/2026 | $435,327 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R33DA060426 | Evaluating Vending Machines providing Naloxone to Prevent Overdose in American Indian Communities | 000 | 3 | NIH | 5/27/2026 | $698,575 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | F31AI194603 | Mechanisms of gene regulation in bacterial defense islands | 000 | 2 | NIH | 8/12/2026 | $46,939 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | K08AI187778 | Enhancing bacteriophage function with coevolution and synthetic biology | 001 | 2 | NIH | 6/22/2026 | $200,446 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01DA062216 | Strengthening Text-based Warning Labels on Cannabis Edible Packages | 001 | 2 | NIH | 4/29/2026 | $819,366 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01DA055369 | 14/24 The Healthy Brain & Child Development National Consortium | 004 | 6 | NIH | 7/27/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01DA055369 | 14/24 The Healthy Brain & Child Development National Consortium | 003 | 6 | NIH | 7/6/2026 | $1,000,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01HL170002 | Molecular basis of ASNA1 cardiomyopathy | 000 | 3 | NIH | 4/29/2026 | $528,874 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | K12TR005441 | CTSA K12 Program at University of California San Diego Altman Clinical and Translational Research Institute | 000 | 2 | NIH | 4/24/2026 | $1,612,278 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01DA055369 | 14/24 The Healthy Brain & Child Development National Consortium | 003 | 6 | NIH | 7/6/2026 | $714,507 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U24DK138512 | An interactive resource to generate and provide integrated knowledge of the human pancreas | 002 | 4 | NIH | 8/21/2026 | $5,545,581 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U24DK138512 | An interactive resource to generate and provide integrated knowledge of the human pancreas | 001 | 3 | NIH | 8/10/2026 | -$1,639,368 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U24DK138512 | An interactive resource to generate and provide integrated knowledge of the human pancreas | 000 | 3 | NIH | 1/8/2026 | $1,960,275 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01DA055369 | 14/24 The Healthy Brain & Child Development National Consortium | 004 | 6 | NIH | 7/27/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | F31AI197841 | Role of Yersiniabactin Precursor Escherichelin in Promoting Enterobacteriaceae Colonization and Pathogenicity of the Inflamed Colon | 001 | 1 | NIH | 5/27/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | F31AI197841 | Role of Yersiniabactin Precursor Escherichelin in Promoting Enterobacteriaceae Colonization and Pathogenicity of the Inflamed Colon | 000 | 1 | NIH | 5/27/2026 | $43,489 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | F31AI186328 | Proteasome Inhibitors as a Novel Drug-class for Treatment of Giardiasis | 001 | 1 | NIH | 5/27/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | F31AI186328 | Proteasome Inhibitors as a Novel Drug-class for Treatment of Giardiasis | 000 | 1 | NIH | 5/27/2026 | $43,626 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | F31AI200294 | Understanding the Structural Basis of PKR Activation by Interferon Gamma RNA | 001 | 1 | NIH | 5/27/2026 | $0 |
|
